Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cornea and External Disease > Key parameters identified for improved visual outcomes in post-keratoplasty astigmatism surgery
  • Cornea and External Disease

Key parameters identified for improved visual outcomes in post-keratoplasty astigmatism surgery

Ophthalmology 360

Femtosecond laser-assisted arcuate keratotomy (FSAK) shows promise in improving visual outcomes for individuals with post-keratoplasty astigmatism, according to a study.

The retrospective analysis included 106 eyes from 104 patients. The majority of cases (89.4%) were attributed to keratoconus (KC), with other conditions such as scar, granular dystrophy, post-LASIK ectasia, and macular dystrophy also represented.

Key findings from the study demonstrated an improvement in uncorrected visual acuity (UCVA) from 1.02±0. to 0.87±0.49 at 3 months and to 0.92±1.08 at 17 months. Best spectacle-corrected visual acuity (BSCVA) also saw improvement from 0.41±0.30 to 0.31±0.19 at 3 months and to 0.23±0.27 at 17 months.

The success rate, defined as an improvement of ≥3 lines on the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, was achieved in 50% (n = 53) at the 3-month follow-up and 49% (n = 52) at the 17-month follow-up. The success group exhibited worse preoperative UCVA (1.21±0.56 vs 0.83±0.44) and worse preoperative BSCVA (0.50±0.36 vs 0.33±0.19).

The study identified a preoperative UCVA cutoff point of 0.90 (equivalent Snellen 20/159) as optimal for predicting success, with 76.9% sensitivity and 35.2% specificity.

The analysis of tomographic parameters revealed a flattening index (FI) of 87% in deep anterior lamellar keratoplasty (DALK) compared to 73% in penetrating keratoplasty (PKP). The correction index was 99% for DALK and 86% for PKP. The success rates for astigmatic surgery in DALK and PKP were 44% and 42%, respectively.

Reference
Alsaif BA, Al Somali A, Banaji SH, Alshaibani AK. Vector Analysis and Prognostic Factors for Femtosecond Arcuate Keratotomy in Post-Keratoplasty Astigmatism. Clin Ophthalmol. 2023;17:3747-3759. doi: 10.2147/OPTH.S429264. PMID: 38089650; PMCID: PMC10712245.

Share

Related Content

  • Cornea and External Disease

Quiz: The impact of blepharitis and conjunctivitis on quality of life

  • Cornea and External Disease

Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient

  • Cornea and External Disease

Cornea specialists identify key clinical signs linked to microbial keratitis subtypes

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

  • Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon